Atlanta residents seeking advanced regenerative medicine no longer need to consider traveling to another country. Springs ...

What remains is not a history of injury, but a present defined by delay - a body still waiting for decisions already made.

CRISPR Therapeutics AG (CRSP) is rated Buy, with a 12-month price target of $64.58, driven by CASGEVY's commercial ramp and a ...

California Now Has Access to Advanced Stem Cell and Exosome Therapy ...

New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a ...

I am a 64-year-old woman, and I was shocked when I was told I have lichen sclerosus. I have lesions on my wrist and arms, ...

A research team from the Department of Orthopedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine at ...

Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...